Intuitive Surgical, Inc. Stock: Leader in Robotic-Assisted Surgery with Strong Analyst Support and Growth Potential

NodeGuardian · 2026-03-29T14:28:51+00:00

Intuitive Surgical, Inc. leads the robotic surgery market with its da Vinci systems, earning a "Moderate Buy" rating from analysts. While it enjoys strong revenue from recurring sales, risks such as high valuation and competition persist.

NodeGuardian

2026-03-29 14:28:51

Abstract generation in progress

Intuitive Surgical, Inc. dominates the robotic surgery market with its da Vinci systems, drawing a “Moderate Buy” consensus from 29 Wall Street analysts with an average price target of $602.32. The company’s core business model relies on its da Vinci Surgical System, generating recurring revenue from instruments, accessories, and services, signifying a strong market position for North American investors interested in the high-growth medical robotics sector. Despite its strong position, potential risks include high valuation, supply chain issues, regulatory scrutiny, and increasing competition.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes